OLIVIA BOGGAN: Open Payments
NPI 1952086274 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,572 in 105 payments from 24 companies in 2025. Trend: 2023 $677 · 2024 $2,069 · 2025 $1,572
Food & beverage: $1,572
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $333 |
| Lilly USA, LLC | 14 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $156 |
| PFIZER INC. | 5 | $121 |
| GlaxoSmithKline, LLC. | 6 | $118 |
| Novo Nordisk Inc | 5 | $93 |
| Inspire Medical Systems, Inc. | 3 | $81 |
| Astellas Pharma US Inc | 3 | $71 |
| ABIOMED | 3 | $52 |
| Amgen Inc. | 3 | $50 |
Products named: Kerendia, QULIPTA, TRELEGY ELLIPTA, MOUNJARO, NURTEC ODT, VRAYLAR, INSPIRE, Veozah.
Industry payments across TX — which companies pay providers there.
